Stem definition | Drug id | CAS RN |
---|---|---|
3035 | 10043-35-3 |
None
None
Date | Agency | Company | Orphan |
---|---|---|---|
None | FDA |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Gastrointestinal toxicity | 367.98 | 61.32 | 80 | 2396 | 7661 | 63478885 |
Pulmonary toxicity | 346.63 | 61.32 | 79 | 2397 | 9376 | 63477170 |
Neoplasm malignant | 260.81 | 61.32 | 80 | 2396 | 29781 | 63456765 |
Joint injury | 257.31 | 61.32 | 79 | 2397 | 29493 | 63457053 |
Hepatotoxicity | 243.84 | 61.32 | 80 | 2396 | 36961 | 63449585 |
C-reactive protein abnormal | 211.48 | 61.32 | 76 | 2400 | 46020 | 63440526 |
Joint stiffness | 207.08 | 61.32 | 73 | 2403 | 41796 | 63444750 |
Therapy non-responder | 187.92 | 61.32 | 80 | 2396 | 75821 | 63410725 |
Musculoskeletal pain | 172.91 | 61.32 | 80 | 2396 | 92197 | 63394349 |
Musculoskeletal stiffness | 123.37 | 61.32 | 81 | 2395 | 184537 | 63302009 |
Treatment failure | 117.82 | 61.32 | 81 | 2395 | 198962 | 63287584 |
Therapeutic product effect incomplete | 108.96 | 61.32 | 65 | 2411 | 124991 | 63361555 |
Infection | 105.31 | 61.32 | 80 | 2396 | 229093 | 63257453 |
Pain in extremity | 87.17 | 61.32 | 84 | 2392 | 331402 | 63155144 |
Joint swelling | 86.09 | 61.32 | 83 | 2393 | 327583 | 63158963 |
Arthropathy | 72.19 | 61.32 | 65 | 2411 | 234727 | 63251819 |
Condition aggravated | 66.88 | 61.32 | 80 | 2396 | 402137 | 63084409 |
Drug hypersensitivity | 63.81 | 61.32 | 69 | 2407 | 310618 | 63175928 |
None
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Gastrointestinal toxicity | 194.57 | 55.70 | 43 | 1671 | 8066 | 79734608 |
Pulmonary toxicity | 174.66 | 55.70 | 43 | 1671 | 12871 | 79729803 |
Joint injury | 136.93 | 55.70 | 43 | 1671 | 31292 | 79711382 |
Neoplasm malignant | 136.29 | 55.70 | 43 | 1671 | 31767 | 79710907 |
Joint stiffness | 121.84 | 55.70 | 42 | 1672 | 40788 | 79701886 |
Hepatotoxicity | 116.11 | 55.70 | 43 | 1671 | 51309 | 79691365 |
C-reactive protein abnormal | 103.83 | 55.70 | 39 | 1675 | 48328 | 79694346 |
Therapy non-responder | 91.75 | 55.70 | 43 | 1671 | 92262 | 79650412 |
Musculoskeletal pain | 87.52 | 55.70 | 43 | 1671 | 102311 | 79640363 |
Treatment failure | 69.51 | 55.70 | 44 | 1670 | 170442 | 79572232 |
Musculoskeletal stiffness | 68.45 | 55.70 | 44 | 1670 | 174964 | 79567710 |
None
Source | Code | Description |
---|---|---|
ATC | S02AA03 | SENSORY ORGANS OTOLOGICALS ANTIINFECTIVES Antiinfectives |
MeSH PA | D007306 | Insecticides |
MeSH PA | D010575 | Pesticides |
CHEBI has role | CHEBI:74783 | adstringent |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Antiseptic preparation | indication | 261276004 |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 4.99 | acidic |
pKa2 | 8.8 | acidic |
None
None
None
ID | Source |
---|---|
R57ZHV85D4 | UNII |
4018204 | VUID |
N0000146538 | NUI |
D01089 | KEGG_DRUG |
4018204 | VANDF |
C0006020 | UMLSCUI |
CHEBI:33118 | CHEBI |
BO3 | PDB_CHEM_ID |
CHEMBL42403 | ChEMBL_ID |
7628 | PUBCHEM_CID |
DB11326 | DRUGBANK_ID |
C032688 | MESH_SUPPLEMENTAL_RECORD_UI |
1700 | RXNORM |
4294 | MMSL |
4907 | MMSL |
003185 | NDDF |
21611007 | SNOMEDCT_US |
346349006 | SNOMEDCT_US |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
Gynetox | HUMAN OTC DRUG LABEL | 21 | 57520-0103 | LIQUID | 12 [hp_X] | ORAL | unapproved homeopathic | 9 sections |
See Clean-One Eye Drops | HUMAN OTC DRUG LABEL | 1 | 58354-105 | LIQUID | 21.64 mg | OPHTHALMIC | unapproved drug other | 8 sections |
Sha-lem | HUMAN OTC DRUG LABEL | 5 | 59862-100 | OINTMENT | 0.95 g | TOPICAL | unapproved drug other | 10 sections |
GYNOX-SOFT | HUMAN OTC DRUG LABEL | 1 | 66854-003 | EMULSION | 7 mg | TOPICAL | unapproved drug other | 8 sections |
ICEKING Skin Expert Anti-onychomycosis Gel | HUMAN OTC DRUG LABEL | 2 | 72501-072 | GEL | 0.20 g | CUTANEOUS | Export only | 7 sections |